Diagnostic Testing Stds

Diagnostic Testing of STDs Market (Laboratory Testing, Point-Of-Care Testing, Laboratory Equipment and Supplies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Rep Id : TMRGL1631
  • Published On : Sep 2013
  • No. of Pages : 90
  • Category : Healthcare

Table of Contents

 

Chapter 1 Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.4 Assumptions

 

Chapter 2 Executive Summary

 

Chapter 3 Introduction: Diagnostic Testing of STDs

3.1 Definition - Diagnostic Testing of STDs

3.2 Significance of STDs, STDs control and prevention

3.3 Types of Diagnostic Tests of STDs

 

Chapter 4 Global Diagnostic Testing of STDs Market Overview

4.1 Overview

4.2 Drivers

      4.2.1 Increasing prevalence and incidence rates of STDs

      4.2.2 National Screening Programs implemented

      4.2.3 Favourable reimbursement for STDs testing

4.3 Restraints

      4.3.1 Stigma associated with voluntary/CICT STD testing

      4.3.2 Large proportion of STD infected patients in out-of-reach geographic areas

      4.3.3 Stringent regulatory compliance requirements for market participants

4.4 Opportunities

      4.4.1 National screening programs across regions - an opportunity for laboratory tests and POC tests / technologies providers

      4.4.2 Declining visits to specialized STD and GUM clinics - an opportunity for public / private labs

      4.4.3 RoW and Asia-Pacific markets - niche opportunity for POC tests/ technologies providers

4.5 Market Attractiveness Analysis: Global Diagnostic Testing of STDs Market, by Geography

 

Chapter 5 Global Diagnostic Testing of STDs Market, by STD Type, 2013 - 2019 (USD Million)

5.1 Chlamydia testing

      5.1.1 Global Chlamydia Diagnostic Testing Market, Volume (in Millions)

      5.1.2 Global Chlamydia Diagnostic Testing Market, Value (USD Million)

5.2 Gonorrhea testing

      5.2.1 Global Gonorrhea Diagnostic Testing Market, Volume (in Millions)

      5.2.2 Global Gonorrhea Diagnostic Testing Market, Value (USD Million)

5.3 P&S Syphilis testing

      5.3.1 Global P&S Syphilis Diagnostic Testing Market, Volume (in Millions)

      5.3.2 Global P&S Syphilis Diagnostic Testing Market, Value (USD Million)

5.4 HPV testing

      5.4.1 Global HPV Diagnostic Testing Market, Volume (in Millions)

      5.4.2 Global HPV Diagnostic Testing Market, Value (USD Million)

5.5 HSV testing

      5.5.1 Global HSV Diagnostic Testing Market, Volume (in Millions)

      5.5.2 Global HSV Diagnostic Testing Market, Value (USD Million)

5.6 HIV testing

      5.6.1 Global HIV Diagnostic Testing Market, Volume (in Millions)

      5.6.2 Global HIV Diagnostic Testing Market, Value (USD Million)

5.7 Chancroid testing

      5.7.1 Global Chancroid Diagnostic Testing Market, Volume (in Millions)

      5.7.2 Global Chancroid Diagnostic Testing Market, Value (USD Million)

5.8 Laboratory Equipment and Supplies Market

 

Chapter 6 Global Diagnostic Testing of STDs Market, by Location, 2013 - 2019 (USD Million)

6.1 Laboratory Testing

6.2 POC Testing

 

Chapter 7 Global Diagnostic Testing of STDs Market, by Geography, 2013 - 2019 (USD Million)

7.1 Introduction

      7.1.1 Global Diagnostic Testing of STDs Market, by Geography, 2013 - 2019 (USD Million)

7.2 Chlamydia Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market Size, 2013 and 2019 (USD Million)

7.3 Gonorrhea Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market Size, 2013 and 2019 (USD Million)

7.4 P&S Syphilis Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market Size, 2013 and 2019 (USD Million)

7.5 HPV Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market Size, 2013 and 2019 (USD Million)

7.6 HSV Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market Size, 2013 and 2019 (USD Million)

7.7 HIV Diagnostic Testing: Regional (North America, Europe, Asia-Pacific & RoW) Market Size, 2013 and 2019 (USD Million)

7.8 Chancroid Diagnostic Testing : Regional (North America, Europe, Asia-Pacific & RoW) Market Size, 2013 and 2019 (USD Million)

 

Chapter 8 Recommendations

8.1 Gain accreditation to ensure qualification to participate in National Screening Programs across regions

8.2 Investment In Laboratory Infrastructure In Developed Regions

8.3 Investing in Asia-Pacific and RoW markets

 

Chapter 9 Company Profiles

9.1 Roche Holdings AG

      9.1.1 Company Overview

      9.1.2 Financial Overview

      9.1.3 Product Portfolio

      9.1.4 Business Strategies 

9.2 Alere, Inc.

      9.2.1 Company Overview

      9.2.2 Financial Overview

      9.2.3 Product Portfolio

      9.2.4 Business Strategies

9.3 Becton Dickinson & Company

      9.3.1 Company Overview

      9.3.2 Financial Overview

      9.3.3 Product Portfolio

      9.3.4 Business Strategies

      9.3.5 Recent Developments

9.4 bioMerieux

      9.4.1 Company Overview

      9.4.2 Financial Overview

      9.4.3 Product Portfolio

      9.4.4 Business Strategies

      9.4.5 Recent Developments

9.5 Danaher Corporation (Beckman Coulter)

      9.5.1 Company Overview

      9.5.2 Financial Overview

      9.5.3 Product Portfolio

      9.5.4 Business Strategies

9.6 Hologic, Inc. (Gen-Probe)

      9.6.1 Company Overview

      9.6.2 Financial Overview

      9.6.3 Product Portfolio

      9.6.4 Business Strategies

 

Chapter 10 Appendix

List of Tables

 

TABLE 1 Market Snapshot: Global Diagnostic Testing of STDs Market

TABLE 2 Global Chlamydia Diagnostic Testing Market, Value, 2011 - 2019 (USD Million)

TABLE 3 Number of Cases of Gonorrhea Resistance (%)

TABLE 4 Global Gonorrhea Diagnostic Testing Market, Value, 2011 - 2019 (USD Million)

TABLE 5 Global P&S Syphilis Diagnostic Testing Market, Value, 2011 - 2019 (USD Million)

TABLE 6 Global HPV Diagnostic Testing Market, Value, 2011 - 2019 (USD Million)

TABLE 7 Global HSV Diagnostic Testing Market, Value, 2011 - 2019 (USD Million)

TABLE 8 Global HIV Diagnostic Testing Market, Value, 2011 - 2019 (USD Million)

TABLE 9 Global Chancroid Diagnostic Testing Market, Value, 2011 - 2019 (USD Million)

List of Figures

 

FIG. 1 Diagnostic Testing of STDs: Market Segmentation

FIG. 2 Global Diagnostic Testing of STDs Market, by STD type, 2012, Volume (in Millions)

FIG. 3 Algorithm for P&S Syphilis testing utilized in screening programs

FIG. 4 Algorithm for HIV testing

FIG. 5 Declining visits to specialized STD clinics

FIG. 6 Market Attractiveness Analysis: Global Diagnostic Testing of STDs Market, by Geography

FIG. 7 Global Chlamydia Diagnostic Testing Market, Volume (in Millions), 2011 - 2019

FIG. 8 Global Gonorrhea Diagnostic Testing Market, Volume (in Millions), 2011 - 2019

FIG. 9 Global P&S Syphilis Diagnostic Testing Market, Volume (in Millions), 2011 - 2019

FIG. 10 Low-risk and High-risk HPV types

FIG. 11 Global HPV Diagnostic Testing Market, Volume (in Millions), 2011 - 2019

FIG. 12 Global HSV Diagnostic Testing Market, Volume (in Millions), 2011 - 2019

FIG. 13 Global HIV Diagnostic Testing Market, Volume (in Millions), 2011 - 2019

FIG. 14 Global Chancroid Diagnostic Testing Market, Volume (in Millions), 2011 - 2019

FIG. 15 Global Diagnostic Testing of STDs Market, by Geography, 2013 - 2019 (USD Million)

FIG. 16 Comparative Analysis : Global Market for Chlamydia Diagnostic Testing, by Geography, 2013 and 2019 (USD million)

FIG. 17 Comparative Analysis : Global Market for Gonorrhea Diagnostic Testing, by Geography, 2013 and 2019 (USD million)

FIG. 18 Comparative Analysis : Global Market for P&S Syphilis Diagnostic Testing, by Geography, 2013 and 2019 (USD million)

FIG. 19 Comparative Analysis : Global Market for HPV Diagnostic Testing, by Geography, 2013 and 2019 (USD million)

FIG. 20 Comparative Analysis : Global Market for HSV Diagnostic Testing, by Geography, 2013 and 2019 (USD million)

FIG. 21 Comparative Analysis : Global Market for HIV Diagnostic Testing, by Geography, 2013 and 2019 (USD million)

FIG. 22 Comparative Analysis : Global Market for Chancroid Diagnostic Testing, by Geography, 2013 and 2019 (USD million)

FIG. 23 Roche Holdings AG: Annual Sales Revenue, USD million, 2010 – 2012

FIG. 24 Alere: Annual Sales Revenue, USD million, 2010 – 2012

FIG. 25 Becton Dickinson: Annual Sales Revenue, USD million, 2010 – 2012

FIG. 26 bioMerieux: Annual Sales Revenue, USD million, 2010 – 2012

FIG. 27 Danaher Corporation: Annual Sales Revenue, USD million, 2010 – 2012

FIG. 28 Hologic: Annual Sales Revenue, USD million, 2010 – 2012

FIG. 29 Healthy People 2020 (HP 2020) Sexually Transmitted Diseases Objectives